BIOMAT Database Logo BIOMAT Database Logo

Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptoms. 1993

T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Department of Paediatrics, Heinrich Heine Universität, Düsseldorf, Germany.

We present the case of a 15-year-old boy with thrombosis of the inferior vena cava, the femoral, inguinal, and renal veins of unknown origin. Although the thrombosis was 2 weeks old, thrombolytic therapy with recombinant tissue-type plasminogen activator (maximum dosage: 0.4 mg/kg/h) was started as this appeared to be the only change to re-establish normal kidney function. After 1 week, treatment was discontinued because of generalized bleeding. At this time, the infrarenal inferior vena cava was again patent with complete lysis of all other clots. Phlebography 3 months after lysis documented an abnormal renal vein, a tubular, subhepatical stenosis of the inferior vena cava and a large collateral vessel between the inferior vena cava and the azygos vein.

UI MeSH Term Description Entries
D008297 Male Males
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D012082 Renal Veins Short thick veins which return blood from the kidneys to the vena cava. Renal Vein,Vein, Renal,Veins, Renal
D005268 Femoral Vein The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein. Femoral Veins,Vein, Femoral,Veins, Femoral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014682 Vena Cava, Inferior The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs. Inferior Vena Cava,Inferior Vena Cavas,Vena Cavas, Inferior

Related Publications

T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
[Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
January 1991, Klinische Padiatrie,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Left ventricular thrombus in a 2-year-old boy with cardiomyopathy: lysis with recombinant tissue-type plasminogen activator.
October 1991, European journal of pediatrics,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Successful treatment of acute inferior vena cava and unilateral renal vein thrombosis by local infusion of recombinant tissue plasminogen activator.
December 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator.
May 1991, Chest,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Interrupted inferior vena cava with deep vein thrombosis.
February 2023, BJR case reports,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
[Thrombosis of the inferior vena cava with successive lung embolization in a 15-year-old boy with nephrotic syndrome].
January 1986, Padiatrie und Padologie,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Venous thrombosis complicating inferior vena cava anomalies in a 7-year-old boy.
February 2003, Pediatric radiology,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Successful catheter intervention for deep vein thrombosis due to inferior vena cava stenosis after retrieval of a temporary inferior vena cava filter.
January 2017, Journal of cardiology cases,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
Inferior Vena Cava agenesis presenting as deep vein thrombosis in an eight year-old girl.
April 2023, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
T Rosenbaum, and S Rammos, and H W Kniemeyer, and U Göbel
[Thrombosis of the inferior vena cava with successive lung embolization in a 15-year-old boy with the nephrotic syndrome].
January 1986, Padiatrie und Padologie,
Copied contents to your clipboard!